HOME > TOP STORIES

TOP STORIES

TRENDS Peak Sales Forecast for New Drugs Listed in 2015 Exceeded 840 Billion Yen with Big Contribution from Hep C Treatments

December 7, 2015
BUSINESS Unusualness of Hep C Market Not Being Understood, Gilead COO Says on Possible Sovaldi Re-Pricing

December 4, 2015
REGULATORY Probe Finds Kaketsuken’s GMP Violations “Extremely Malicious”, MHLW to Impose Penalty

December 3, 2015
REGULATORY NHI-Market Price Gap at 8.8%, 6.8% Price Cut Expected in FY2016 Revision

December 3, 2015
REGULATORY MHLW Discussing Use of Disease Registry as Substitute for Control Groups; Could Be “One Means of Evaluation” in Trials for Rare Diseases

December 2, 2015
BUSINESS Mitsubishi Tanabe Set to Derive 40% of Sales Abroad in FY2020, Shed 1,200 Jobs over 5 Years

December 1, 2015
BUSINESS Takeda, Teva Hook Up to Form Generic Joint Venture in Japan

November 30, 2015
TRENDS AG Shares Reach 50-60% in 1 Year; Confidence in Quality Encourages Dominance Even without Market Lead

November 30, 2015
REGULATORY Evaluation of Efficacy Was Challenging in Sakigake Pick, Designating All Qualified Drugs Desirable: MHLW Official

November 27, 2015
REGULATORY Drug Pricing Debate to Culminate in December; Abraxane, Zosyn Major Candidates for Market Expansion Re-Pricing

November 26, 2015
REGULATORY Don’t Seek Near-Term Profits but Have Long-Term Vision, MHLW Official Tells Drug Makers

November 25, 2015
REGULATORY MHLW Eyes Using HTA to Re-Price Drugs with Big Sales Outlooks That Have Gone Through 1 or 2 Price Revisions

November 24, 2015
ACADEMIA Viekirax Joins Fray in Hep C Market, Can It Crack into Harvoni’s Stronghold?

November 20, 2015
ORGANIZATION Industry Wants OTC Tax Break and No Annual Price Cuts, Groups Tell LDP

November 19, 2015
REGULATORY AbbVie’s Hep C Drug Viekirax Priced at 53,000 Yen Daily vs. Harvoni’s 80,000 Yen

November 18, 2015
BUSINESS Generic Makers’ Earnings Show Unabated Momentum 1 Year after Medical Fee Reform: Tally

November 17, 2015
BUSINESS AZ Eyes Low Single-Digit Growth over Coming Years in Japan: Pres. Baertschi

November 16, 2015
REGULATORY Business Improvement Order Issued to Novartis Japan

November 13, 2015
REGULATORY Chuikyo Subcommittee Broadly OKs Price Maintenance Rule for Essential Drugs

November 12, 2015
BUSINESS Top 4 Wholesalers See 7% Sales Rise on Hep C Drugs, but Paltry 0.82% in Operating Margin

November 11, 2015

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?

Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…